» Authors » Stephan Bartels

Stephan Bartels

Explore the profile of Stephan Bartels including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 311
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hupe H, Wienecke C, Bartels S, Schipper E, Lessmann J, Lasch A, et al.
Hemasphere . 2025 Mar; 9(3):e70097. PMID: 40066001
Isolated extramedullary manifestations (IEM) of acute myeloid leukemia (AML) are recurrent events, especially following allogeneic hematopoietic cell transplantation (alloHCT). To date, measurable residual disease (MRD) assessment for this difficult-to-treat patient...
2.
Radner M, Burmeister S, Jozwiak K, Schaumann N, Gronewold M, Raap M, et al.
Lab Invest . 2025 Mar; :104125. PMID: 40049332
Background: Invasive lobular carcinoma with tubular elements (ILC-TE) is a recently identified variant of invasive lobular breast carcinoma (ILC). The histology of ILC-TE is defined by non-cohesive carcinoma cells mixed...
3.
Odensass M, Bartels S, Schlue J, Busche G, Kreipe H, Lehmann U
Virchows Arch . 2024 Nov; PMID: 39537990
The majority of mastocytosis cases are characterized by an activating mutation in the KIT gene in codon 816. The detection of this alteration is of importance for proper diagnostic workup....
4.
Sandbothe M, Hasemeier B, Schipper E, Schaumann N, Kreipe H, Lehmann U, et al.
Virchows Arch . 2024 Oct; PMID: 39392509
Molecular analysis of circulating cell-free DNA (cfDNA) extracted from peripheral blood plasma samples of metastatic breast cancer (BC) patients is of rising interest to find optimal therapeutic strategies. Detection of...
5.
Menzel M, Martis-Thiele M, Goldschmid H, Ott A, Romanovsky E, Siemanowski-Hrach J, et al.
Eur J Cancer . 2024 Sep; 211:114306. PMID: 39293347
Introduction: Whole Exome Sequencing (WES) has emerged as an efficient tool in clinical cancer diagnostics to broaden the scope from panel-based diagnostics to screening of all genes and enabling robust...
6.
Gronewold M, Grote I, Bartels S, Christgen H, Kandt L, Brito M, et al.
J Pathol Clin Res . 2024 Apr; 10(2):e12361. PMID: 38618992
Invasive lobular carcinoma (ILC) is a special breast cancer type characterized by noncohesive growth and E-cadherin loss. Focal activation of P-cadherin expression in tumor cells that are deficient for E-cadherin...
7.
Hobeck A, Wendt S, Krohn S, Knuebel G, Bartels S, Schipper E, et al.
Int J Mol Sci . 2024 Mar; 25(6). PMID: 38542506
Next-generation sequencing is a vital tool for personalized diagnostics and therapies in cancer. Despite numerous advantages, the method depends on multiple parameters regarding the sample material, e.g., sample fixation. A...
8.
Pfarr N, von Schwarzenberg K, Zocholl D, Merkelbach-Bruse S, Siemanowski J, Mayr E, et al.
JCO Precis Oncol . 2024 Mar; 8:e2300348. PMID: 38513168
Purpose: Poly(ADP-ribose) polymerase inhibitors (PARPi) have shown promising clinical results in the treatment of ovarian cancer. Analysis of biomarker subgroups consistently revealed higher benefits for patients with homologous recombination deficiency...
9.
Schaumann N, Bartels S, Kuehnle E, Kreipe H, Christgen M
Pathol Res Pract . 2024 Jan; 254:155100. PMID: 38277744
Phyllodes tumor (PT) of the breast is a biphasic neoplasia composed of mesenchymal and epithelial cells. PTs are graded as benign, borderline or malignant according to histological criteria. Invasive lobular...
10.
Grote I, Poppe A, Lehmann U, Christgen M, Kreipe H, Bartels S
Genes Chromosomes Cancer . 2023 Sep; 63(1):e23199. PMID: 37672607
About 20%-30% of breast cancer (BC) patients will develop distant metastases, preferentially in bones, liver, lung, and brain. BCs with different intrinsic subtypes prefer different sites for metastasis. These subtypes...